Literature DB >> 25859456

To evaluate the different rapid screening tests for diagnosis of leptospirosis.

Tanvi Panwala1, Sangeeta Rajdev1, Summaiya Mulla2.   

Abstract

INTRODUCTION: Leptospirosis is an acute febrile disease, in tropical and sub-tropical regions of world. It has been under-reported in India, due to presence of non-specific symptoms and unavailability of appropriate laboratory diagnostic facilities in most part of the country. The diagnosis of leptospirosis is usually based on demonstration of antibodies by different serological tests. AIM: The present study aims to evaluate and compare commercially available rapid test. DESIGN AND SETTINGS: Case control study.
MATERIALS AND METHODS: Three screening tests (Leptocheck WB, Latex agglutination test and SD leptospira) were compared by using 100 serum samples randomly obtained from clinical cases of Leptospirosis admitted in new civil hospital, Surat, Gujarat. All the patients with acute Leptospirosis were included in this 4-months pilot study from July 2011 to October 2011. All the results were compared with IgM ELISA and MAT for confirmation of diagnosis.
RESULTS: Leptocheck WB, Latex agglutination test and SD leptospira had sensitivities of 84.8%, 84.8% and 72.7% & specificities of 37.3%, 71.2% and 71.2% respectively as compared to MAT. Leptocheck WB, Latex agglutination test and SD leptospira had sensitivities of 90.7%, 89.7% and 53.7% & specificities of 93.4%, 90.9% and 60% respectively as compared to IgM ELISA.
CONCLUSION: Latex agglutination test kit and Leptocheck WB were found to be highly sensitive and specific. Neither of these tests require specialized equipment, and could be performed in peripheral laboratories with relatively little expertise.

Entities:  

Keywords:  IgM ELISA; Leptocheck; Leptorapide; Leptospirosis; MAT; SD leptospira IgM/IgG

Year:  2015        PMID: 25859456      PMCID: PMC4378738          DOI: 10.7860/JCDR/2015/11188.5587

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  16 in total

1.  Leptospirosis worldwide, 1999.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  1999-07-23

2.  Evaluation of microscopic agglutination test as a diagnostic tool during acute stage of leptospirosis in high & low endemic areas.

Authors:  P Vijayachari; A P Sugunan; S C Sehgal
Journal:  Indian J Med Res       Date:  2001-09       Impact factor: 2.375

Review 3.  Overview of the epidemiology, microbiology, and pathogenesis of Leptospira spp. in humans.

Authors:  R Plank; D Dean
Journal:  Microbes Infect       Date:  2000-08       Impact factor: 2.700

4.  Evaluation of four commercially available rapid serologic tests for diagnosis of leptospirosis.

Authors:  Mary D Bajani; David A Ashford; Sandra L Bragg; Christopher W Woods; Tin Aye; Richard A Spiegel; Brian D Plikaytis; Bradley A Perkins; Maureen Phelan; Paul N Levett; Robbin S Weyant
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

5.  Comparison of an in-house latex agglutination test with IgM ELISA and MAT in the diagnosis of leptospirosis.

Authors:  S Shekatkar; N S Acharya; B N Harish; S C Parija
Journal:  Indian J Med Microbiol       Date:  2010 Jul-Sep       Impact factor: 0.985

6.  Leptospirosis: prognostic factors associated with mortality.

Authors:  H Dupont; D Dupont-Perdrizet; J L Perie; S Zehner-Hansen; B Jarrige; J B Daijardin
Journal:  Clin Infect Dis       Date:  1997-09       Impact factor: 9.079

7.  Evaluation of a commercial enzyme-linked immunosorbent assay for detection of immunoglobulin M antibody in diagnosis of human leptospiral infection.

Authors:  W E Winslow; D J Merry; M L Pirc; P L Devine
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

8.  Evaluation of the indirect hemagglutination assay for diagnosis of acute leptospirosis.

Authors:  P N Levett; C U Whittington
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

9.  Evaluation of an immunoenzymatic test (ELISA) for the diagnosis of leptospirosis in Italy.

Authors:  M Cinco; D Balanzin; E Banfi
Journal:  Eur J Epidemiol       Date:  1992-09       Impact factor: 8.082

10.  Prospective evaluation of three rapid diagnostic tests for diagnosis of human leptospirosis.

Authors:  Marga G A Goris; Mariska M G Leeflang; Martin Loden; Jiri F P Wagenaar; Paul R Klatser; Rudy A Hartskeerl; Kimberly R Boer
Journal:  PLoS Negl Trop Dis       Date:  2013-07-11
View more
  6 in total

1.  Polymerase Chain Reaction: An Important Tool for Early Diagnosis of Leptospirosis Cases.

Authors:  Summaiya Mullan; Tanvi Harivadanbhai Panwala
Journal:  J Clin Diagn Res       Date:  2016-12-01

2.  Rapid diagnostic test (Leptocheck-WB) for detection of acute leptospirosis: a meta-analysis of diagnostic accuracy.

Authors:  Norah Htet Htet; Wong Siew Tung; Siau Ek Hwee; Cho Naing; Joon Wah Mak
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-02-11       Impact factor: 3.267

3.  Evaluation of a Commercial Immuno-Chromatographic Assay Kit for Rapid Detection of IgM Antibodies against Leptospira Antigen in Human Serum.

Authors:  Fairuz Amran; Yii Ling Liow; Nurul Atiqah Noor Halim
Journal:  J Korean Med Sci       Date:  2018-04-12       Impact factor: 2.153

4.  A prospective study to evaluate the accuracy of rapid diagnostic tests for diagnosis of human leptospirosis: Result from THAI-LEPTO AKI study.

Authors:  Janejira Dinhuzen; Umaporn Limothai; Sasipha Tachaboon; Panadda Krairojananan; Bangon Laosatiankit; Sakarin Boonprasong; Nuttha Lumlertgul; Sadudee Peerapornratana; Nattachai Srisawat
Journal:  PLoS Negl Trop Dis       Date:  2021-02-19

5.  Application of PCR for Specific Diagnosis of Leptospirosis in Humans in Ukraine.

Authors:  Olena Zubach; Oksana Semenyshyn; Lilya Vasiuynets; Oksana Velychko; Alexander Zinchuk
Journal:  Pol J Microbiol       Date:  2020-12-27

Review 6.  Micronutrients and Leptospirosis: A Review of the Current Evidence.

Authors:  Heather S Herman; Saurabh Mehta; Washington B Cárdenas; Anna M Stewart-Ibarra; Julia L Finkelstein
Journal:  PLoS Negl Trop Dis       Date:  2016-07-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.